ACSL4 as a Potential Target and Biomarker for Anticancer: From Molecular Mechanisms to Clinical Therapeutics
Jun Hou(Third People's Hospital of Chengdu), Zhen Zhang(Suzhou Municipal Hospital), Shiqiang Xiong(Third People's Hospital of Chengdu), Xudong Wen(Chengdu University of Traditional Chinese Medicine), Pan Long(Sichuan University), Chengming Li(Dalian Medical University), Jianyou Shi(University of Electronic Science and Technology of China), Tian Yue(Third People's Hospital of Chengdu), Changqing Jiang(Capital Medical University)
Cited by 92
Related Papers
Recent advances in the development of protein–protein interactions modulators: mechanisms and clinical trials
|Signal Transduction and Targeted Therapy|2020|893
MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p/AMPK/PGC1α/CEBPB axis to promote stemness and chemo-resistance of gastric cancer
|Cell Death and Disease|2020|290
A New Class of Biochemically Degradable, Stimulus‐Responsive Triblock Copolymer Gelators
|Angewandte Chemie International Edition|2006|237
New Perspectives for the Design of Molecular Actuators: Thermally Induced Collapse of Single Macromolecules from Cylindrical Brushes to Spheres
|Angewandte Chemie International Edition|2004|204
Synthesis and Characterization of Biocompatible Thermo-Responsive Gelators Based on ABA Triblock Copolymers
|Biomacromolecules|2005|166